|19th October 2020||Ruth Dreessen||1,748||Grant/award etc.||$0.00|
|1st October 2020||Johannes Minho Roth||652||Grant/award etc.||$0.00|
|28th September 2020||Andrew Marsh||550,000||Grant/award etc.||$0.00|
|31st August 2020||Andrew Marsh||104,412||Open or private sale||$12.98||$1,354,902.32|
|28th August 2020||Andrew Marsh||166,666||Open or private sale||$12.95||$2,158,524.70|
|28th August 2020||Andrew Marsh||166,666||Exercise of derivative||$1.96||$326,665.36|
|28th August 2020||Andrew Marsh||166,666||Exercise of derivative||$0.00|
|28th August 2020||Andrew Marsh||80,284||Payment by withholding||$13.07||$1,049,311.88|
|19th August 2020||Andrew Marsh||108,333||Exercise of derivative||$2.62||$283,832.46|
|19th August 2020||Andrew Marsh||108,333||Exercise of derivative||$2.23||$241,582.59|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 5/10.
Gevo, Inc. is a renewable chemicals and next generation biofuels company. The company focuses on the development and commercialization of renewable alternatives to petroleum-based products. It operates through the following segments. The Gevo segment focuses in research and development activities related to the future production of isobutanol.